Loading clinical trials...

Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDPhase 2NCT02764229

Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis

The purpose of this study is to allow subjects completing study LYC-30937-2001 the opportunity to receive LYC-30937-EC 25 mg.

Lead sponsor: Lycera Corp.•9 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

NCT06651281 · Crohn Disease, Colitis, Ulcerative

RECRUITING

A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis

NCT06294925 · Colitis, Ulcerative

RECRUITINGPhase 2/3

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

NCT05076175 · Colitis, Ulcerative

RECRUITING

Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis

NCT06359808 · Colitis, Ulcerative, Sleep Quality, and more

RECRUITINGNA

Diet Intervention Treatment for Active Ulcerative Colitis

NCT04121806 · Colitis, Ulcerative

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 27, 2019Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment112

Start dateNov 2016

Last updatedMar 27, 2019

Condition

Colitis, Ulcerative

Locations shown

Lycera Investigational Site

Little Rock, Arkansas

Lycera Investigational Site

Mission Hills, California

Lycera Investigational Site

Miami, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 27, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis

Diet Intervention Treatment for Active Ulcerative Colitis

Trial snapshot

Condition

Locations shown

For caregivers